Advanced search
Publication Cover
International Journal of Nephrology and Renovascular Disease Volume 9, 2016 - Issue
Submit an article Journal homepage
248
Views
23
CrossRef citations to date
0
Altmetric
Review

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide

Valeria CernaroDepartment of Clinical and Experimental Medicine, University of Messina, Messina, ItalyCorrespondence[email protected]
,
Domenico SantoroDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy
,
Antonio LacquanitiDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy
,
Giuseppe CostantinoDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy
,
Luca ViscontiDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy
,
Antoine BuemiDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy
&
Michele BuemiDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy
 show all
Pages 11-19 | Published online: 02 Feb 2016

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Valeria Cernaro, Elisa Longhitano, Vincenzo Calabrese, Chiara Casuscelli, Silvia Di Carlo, Claudia Spinella, Guido Gembillo & Domenico Santoro. (2023) Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure. Expert Opinion on Pharmacotherapy 24:15, pages 1737-1746.
Read now
Jose Antonio Herrero, Mario Salomone, Antonio Ramirez de Arellano, Thilo Schaufler & Sebastian Walpen. (2021) Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysis. Journal of Medical Economics 24:1, pages 1240-1247.
Read now
Valeria Cernaro, Sebastiano Calimeri, Alfredo Laudani & Domenico Santoro. (2020) Clinical Evaluation of the Safety, Efficacy and Tolerability of Lanthanum Carbonate in the Management of Hyperphosphatemia in Patients with End-Stage Renal Disease. Therapeutics and Clinical Risk Management 16, pages 871-880.
Read now

Articles from other publishers (20)

Seth Bollenbecker, Brian Czaya, Orlando M. Gutiérrez & Stefanie Krick. (2022) Lung-kidney interactions and their role in chronic kidney disease-associated pulmonary diseases. American Journal of Physiology-Lung Cellular and Molecular Physiology 322:5, pages L625-L640.
Crossref
Magdalena Bäumler, Sebastian P. Schwaminger, Daniela von der Haar-Leistl, Simon J. Schaper, Peter Müller-Buschbaum, Friedrich E. Wagner & Sonja Berensmeier. (2021) Characterization of an active ingredient made of nanoscale iron(oxyhydr)oxide for the treatment of hyperphosphatemia. RSC Advances 11:29, pages 17669-17682.
Crossref
Min Li, Xianlin Fan, Qian Mao, Qing Li, Xiujuan Zhang, Gaohong He, Shufen Zhang & Wenjun Zhang. (2021) The hollow core-shell ferric oxide entrapped chitosan microcapsules as phosphate binders for phosphorus removal in vitro. Carbohydrate Polymers 257, pages 117621.
Crossref
Takashi Shigematsu, Yotaro Une, Kazuaki Ikejiri, Hironori Kanda, Masafumi Fukagawa & Tadao Akizawa. (2021) Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia. American Journal of Nephrology 52:6, pages 496-506.
Crossref
Giuseppe Coppolino, Ramona Nicotera, Valeria Cernaro, Sebastiano Calimeri, Giuseppe Leonardi, Sonia Cosentino, Alessandro Comi, Cinzia Donato, Citraro Maria Lucia, Michele Provenzano, Ashour Michael & Michele Andreucci. (2019) Iron Infusion and Induced Hypophosphatemia: The Role of Fibroblast Growth Factor‐23. Therapeutic Apheresis and Dialysis 24:3, pages 258-264.
Crossref
Annabel Biruete, Kathleen M. Hill Gallant, Stephen R. Lindemann, Gretchen N. Wiese, Neal X. Chen & Sharon M. Moe. (2020) Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract. Journal of Renal Nutrition 30:1, pages 4-10.
Crossref
S. A. Martynov & M. Sh. Shamkhalova. (2019) Hyperphosphatemia in chronic kidney disease. Medical Council:16, pages 78-85.
Crossref
Wen Jen Lin & Shu An Lee. (2019) A novel iron-conjugated acid-modified chitosan derivatives as an oral phosphate binding agent to improve phosphorus adsorption efficacy in vitro and in vivo, synthesis and their characterization. Carbohydrate Polymers 212, pages 378-386.
Crossref
Alexander Brauer, Sana Waheed, Tripti Singh & Laura Maursetter. (2019) Improvement in Hyperphosphatemia Using Phosphate Education and Planning Talks. Journal of Renal Nutrition 29:2, pages 156-162.
Crossref
Grzegorz B. Wasilewski, Marc G. Vervloet & Leon J. Schurgers. (2019) The Bone—Vasculature Axis: Calcium Supplementation and the Role of Vitamin K. Frontiers in Cardiovascular Medicine 6.
Crossref
Aristeidis Stavroulopoulos, Vasiliki Aresti, Christoforos Papadopoulos, Panagiotis Nennes, Polixeni Metaxaki & Anastasios Galinas. (2018) Bicarbonate levels in hemodialysis patients switching from lanthanum carbonate to sucroferric oxyhydroxide. World Journal of Nephrology 7:6, pages 123-128.
Crossref
Jordan Zuvela, Claire Trimingham, Richard Le Leu, Randall Faull, Philip Clayton, Shilpa Jesudason & Anthony Meade. (2018) Gastrointestinal symptoms in patients receiving dialysis: A systematic review. Nephrology 23:8, pages 718-727.
Crossref
Dengpiao Xie, Naijing Ye & Mingquan Li. (2018) A systematic review on the efficacy and safety of PA21 versus sevelamer in dialysis patients. International Urology and Nephrology 50:5, pages 905-909.
Crossref
Luca Visconti, Valeria Cernaro, Sebastiano Calimeri, Antonio Lacquaniti, Francesca De Gregorio, Carlo Alberto Ricciardi, Viviana Lacava, Domenico Santoro & Michele Buemi. (2018) The Myth of Water and Salt: From Aquaretics to Tenapanor. Journal of Renal Nutrition 28:2, pages 73-82.
Crossref
Xiuqin Yang, Qingning Bai, Yanguo Li, Haijun Liu, Haiying Guo & Xiaolei Zhang. (2017) Comparative Efficacy and Safety of Phosphate Binders in Hyperphosphatemia Patients With Chronic Kidney Disease. Journal of Parenteral and Enteral Nutrition, pages 014860711771544.
Crossref
Lalita Prasad-Reddy, Diana Isaacs & Alexander Kantorovich. (2017) Considerations and controversies in managing chronic kidney disease: An update. American Journal of Health-System Pharmacy 74:11, pages 795-810.
Crossref
Nigar Sekercioglu, Argie Angeliki Veroniki, Lehana Thabane, Jason W. Busse, Noori Akhtar-Danesh, Alfonso Iorio, Luciane Cruz Lopes & Gordon H. Guyatt. (2017) Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA. PLOS ONE 12:3, pages e0171028.
Crossref
Nigar Sekercioglu, Reem Al-Khalifah, Joycelyne Efua Ewusie, Rosilene M. Elias, Lehana Thabane, Jason W. Busse, Noori Akhtar-Danesh, Alfonso Iorio, Tetsuya Isayama, Juan Pablo Díaz Martínez, Ivan D. Florez & Gordon H. Guyatt. (2016) A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument. International Urology and Nephrology 49:2, pages 273-284.
Crossref
Naoko Murakami, Masao Yoshioka, Masaya Iwamuro, Junichirou Nasu, Soichiro Nose, Junji Shiode, Hiroyuki Okada & Kazuhide Yamamoto. (2017) Clinical Characteristics of Seven Patients with Lanthanum Phosphate Deposition in the Stomach. Internal Medicine 56:16, pages 2089-2095.
Crossref
Nigar Sekercioglu, Lehana Thabane, Juan Pablo Díaz Martínez, Gihad Nesrallah, Christopher J. Longo, Jason W. Busse, Noori Akhtar-Danesh, Arnav Agarwal, Reem Al-Khalifah, Alfonso Iorio & Gordon H. Guyatt. (2016) Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. PLOS ONE 11:6, pages e0156891.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.